A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis
Clinical trial NCT01626573 · COMPLETED
Trial details
- NCT number
- NCT01626573
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-07-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.